Robert J. Morgan
Impact in
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
- Urology top 1%
- Urinary Bladder and Prostate Research
Papers in
-
- Ovarian cancer diagnosis and treatment 35
- Urology 16
- Urinary Bladder and Prostate Research 15
- Co-authors
- Iván SoltészJames H. DoroshowDavid R. GandaraGeorge SomloAmit M. OzaGini F. FlemingLucille LeongD.P. Mikhailidis
- Journals
- Journal of Clinical Oncology (28 papers)Cancer Chemotherapy and Pharmacology (19 papers)Journal of the National Comprehensive Cancer Network (9 papers)Gynecologic Oncology (8 papers)Clinical Cancer Research (5 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Robert J. Morgan
188 papers receiving 5.7k citations
Peers
Comparison fields: 5 of 162
- Reproductive Medicine 881
- Urology 378
- Oncology 1.6k
- Psychiatry and Mental health 698
- Cancer Research 560
Countries citing papers authored by Robert J. Morgan
This map shows the geographic impact of Robert J. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Morgan more than expected).
Fields of papers citing papers by Robert J. Morgan
This network shows the impact of papers produced by Robert J. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Morgan. The network helps show where Robert J. Morgan may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert J. Morgan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 14 | |
| 2 | 2023 | 26 | |
| 3 | 2020 | 2 | |
| 4 | 2020 | 9 | |
| 5 | 2019 | 25 | |
| 6 | 2018 | 54 | |
| 7 | 2018 | 49 | |
| 8 | 2012 | 155 | |
| 9 | 2012 | 6 | |
| 10 | 2011 | 22 | |
| 11 | 2010 | 71 | |
| 12 | 2008 | 137 | |
| 13 | A Phase 2 study of AZD2171 in recurrent or persistent ovarian, peritoneal or fallopian tube cancer. A study of the PMH, Chicago, and California Phase II Consortia | 2007 | 1 |
| 14 | 2006 | 3 | |
| 15 | 1999 | 126 | |
| 16 | 1995 | 47 | |
| 17 | 1993 | 58 | |
| 18 | 1992 | 18 | |
| 19 | FOCUS: Beaton Institute of Cape Breton Studies | 1977 | 1 |
| 20 | 1966 | 0 |
About Robert J. Morgan
Robert J. Morgan is a scholar working on Reproductive Medicine, Urology, Oncology, Psychiatry and Mental health and Cancer Research, having authored 197 papers that have together received 5.8k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (35 papers), Cancer Treatment and Pharmacology (23 papers), Sexual function and dysfunction studies (17 papers), Hormonal and reproductive studies (15 papers), Urinary Bladder and Prostate Research (15 papers), Intraperitoneal and Appendiceal Malignancies (14 papers), Cancer therapeutics and mechanisms (11 papers) and BRCA gene mutations in cancer (9 papers). The work is most often cited by research in Reproductive Medicine (881 citations), Urology (378 citations), Oncology (1.6k citations), Psychiatry and Mental health (698 citations) and Cancer Research (560 citations). Robert J. Morgan has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Iván Soltész, James H. Doroshow, David R. Gandara, George Somlo, Amit M. Oza, Gini F. Fleming, Lucille Leong, D.P. Mikhailidis, Kim Margolin and Dean Lim. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Journal of the National Comprehensive Cancer Network, Gynecologic Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.